| Literature DB >> 30949214 |
Ratree Ruangthai1, Jatuporn Phoemsapthawee1.
Abstract
BACKGROUND/Entities:
Keywords: Aging; Antioxidant defense; Combined exercise training; Inflammation; Lipid peroxidation
Year: 2019 PMID: 30949214 PMCID: PMC6430041 DOI: 10.1016/j.jesf.2019.03.001
Source DB: PubMed Journal: J Exerc Sci Fit ISSN: 1728-869X Impact factor: 3.103
Characteristics of subjects.
| CON | ET | ST | CBT | |
|---|---|---|---|---|
| (n = 12) | (n = 13) | (n = 13) | (n = 16) | |
| Age (years) | 66.7 | 65.6 | 68 | 67.3 |
| Gender (male/female) | 5/7 | 1/12 | 0/13† | 5/11 |
| Height (cm) | 157.6 | 156.6 | 151.8 | 157.6 |
| Weight (kg) | 63.4 | 58.5 | 52.3 | 60.2 |
| BMI (kg | 25.6 | 23.8 | 22.6 | 24.1 |
| MMSE | 28.8 | 28.4 | 28.6 | 28.4 |
| Medication | ||||
| Antihypertensive‡ | 7 (58.3%) | 6 (46.2%) | 6 (46.2%) | 8 (50%) |
| Antihyperglycemia | 2 (16.7%) | 1 (7.7%) | 2 (15.4%) | 2 (12.5%) |
| Lipid-lowering drug therapy | 5 (41.7%) | 5 (38.5%) | 6 (46.2%) | 5 (31.3%) |
Data are means SD and n(%). CON, control group; ET, endurance training group; ST, strength training group; CBT, combined endurance and strength training group; BMI, body mass index; MMSE, Mini-Mental State Examination.
*p 0.05 vs. control group. for categorical variables.
†p 0.05 to between-group comparison.
‡Comprises hydrochlorothiazide (25 mg), propranolol (40 mg), captopril (25 mg), enalapril (10 mg), losartan (50 mg), and amlodipine (5 mg).
Fig. 1Flowchart of the study.
Body composition and physiological outcomes before and after the supervised and the self-supervised training periods.
| CON | ET | ST | CBT | |
|---|---|---|---|---|
| (n = 12) | (n = 13) | (n = 13) | (n = 16) | |
| Weight (kg) | ||||
| Baseline | 63.4 | 58.5 | 52.3 | 60.2 |
| After supervised period | 61.5 | 58.2 | 51.9 | 59.8 |
| After self-supervised period | 63.4 | 58.1 | 51.9 | 59.3 |
| BMI (kg | ||||
| Baseline | 25.6 | 23.8 | 22.6 | 24.1 |
| After supervised period | 25 | 23.7 | 22.4 | 24 |
| After self-supervised period | 25.6 | 23.7 | 22.5 | 23.9 |
| FM (kg) | ||||
| Baseline | 22.6 | 18.8 | 17.7 | 19.4 |
| After supervised period | 20.8 | 18.4 | 17.1 | 18.7 |
| After self-supervised period | 23.1 | 17.9 | 17 | 18.3 |
| %BF | ||||
| Baseline | 35.3 | 32.3 | 33.4 | 32.3 |
| After supervised period | 33.8 | 31.7 | 32.3 | 31.4 |
| After self-supervised period | 35.8 | 30.8 | 32.3 | 31.8 |
| SMM (kg) | ||||
| Baseline | 22 | 21.3 | 18.1 | 21.9 |
| After supervised period | 22 | 21.4 | 18.2 | 22.1 |
| After self-supervised period | 21.9 | 21.5 | 18.3 | 21.5 |
| HR (beats | ||||
| Baseline | 71.9 | 77.5 | 73 | 75.6 |
| After supervised period | 73.4 | 79.4 | 72.9 | 74.3 |
| After self-supervised period | 74.9 | 82 | 72.3 | 74.2 |
| SBP (mmHg) | ||||
| Baseline | 140.6 | 141 | 146.8 | 142 |
| After supervised period | 142.1 | 128.3 | 141.8 | 130.4 |
| After self-supervised period | 147.3 | 133.3 | 144.8 | 131.4 |
| DBP (mmHg) | ||||
| Baseline | 82.5 | 84.1 | 80.5 | 81.7 |
| After supervised period | 82.1 | 76.6 | 74.4 | 76.9 |
| After self-supervised period | 81.5 | 80.1 | 76.6 | 73.6 |
| MAP (mmHg) | ||||
| Baseline | 93.4 | 95.1 | 102.6 | 101.8 |
| After supervised period | 96.6 | 93.8 | 89.4 | 94.8 |
| After self-supervised period | 94.8 | 97.8 | 99.4 | 92.9 |
Data are means SD. CON, control group; ET, endurance training group; ST, strength training group; CBT, combined endurance and strength training group; BMI, body mass index; FM, fat mass; %BF, body fat percentage; SMM, skeletal muscle mass; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure.
∗p 0.05 and ∗∗p 0.01 to within-group comparison (baseline vs. after supervised period vs. after self-supervised period).
†p 0.05 and ††p 0.01 to between-group comparison (vs. control group).
Biochemical outcomes before and after the supervised and the self-supervised training periods.
| CON | ET | ST | CBT | |
|---|---|---|---|---|
| (n = 12) | (n = 13) | (n = 13) | (n = 16) | |
| FBG (mg | ||||
| Baseline | 97.1 | 88.2 | 89.2 | 95.7 |
| After supervised period | 104.6 | 92 | 106 | 99.1 |
| After self-supervised period | 95.7 | 88.4 | 92.3 | 92.9 |
| TC (mg | ||||
| Baseline | 201.4 | 210.7 | 200.8 | 203.8 |
| After supervised period | 211.8 | 211.3 | 195.1 | 209 |
| After self-supervised period | 202.4 | 208.3 | 192 | 202 |
| TG (mg | ||||
| Baseline | 151.5 | 122.1 | 95.6 | 96.5 |
| After supervised period | 143.3 | 134 | 95.1 | 109.5 |
| After self-supervised period | 140.8 | 125.8 | 83.2 | 93.4 |
| LDL-C (mg | ||||
| Baseline | 122.6 | 136.1 | 123.2 | 128.8 |
| After supervised period | 133.3 | 127.8 | 118.8 | 124.3 |
| After self-supervised period | 124.3 | 126.8 | 109.9 | 125.4 |
| HDL-C (mg | ||||
| Baseline | 48.6 | 53.8 | 58.5 | 55.9 |
| After supervised period | 49.9 | 56.8 | 57.5 | 57.3 |
| After self-supervised period | 49.9 | 56.4 | 65.7 | 57.5 |
| TC/HDL-C ratio | ||||
| Baseline | 4.2 | 4 | 3.5 | 3.8 |
| After supervised period | 4.4 | 3.9 | 3.4 | 3.8 |
| After self-supervised period | 4.1 | 3.9 | 3 | 3.7 |
| LDL-C/HDL-C ratio | ||||
| Baseline | 2.5 | 2.4 | 2.1 | 2.5 |
| After supervised period | 2.8 | 2.4 | 2.1 | 2.3 |
| After self-supervised period | 2.5 | 2.3 | 1.7 | 2.4 |
Data are means SD. CON, control group; ET, endurance training group; ST, strength training group; CBT, combined endurance and strength training group; FBG, fasting blood glucose; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol.
∗p 0.05 and ∗∗p 0.01 to within-group comparison (baseline vs. after supervised period vs. after self-supervised period).
Fig. 2Plasma glutathione peroxidase (A), total nitrite/nitrate (B), malondialdehyde (C), and serum high-sensitive C-reactive protein (D) before (black) and after the supervised training period (white) and after the self-supervised training period (gray). Data are means SD. CON, control group; ET, endurance training group; ST, strength training group; CBT, combined endurance and strength training group. ∗p 0.05 and ∗∗p 0.01 to within-group comparison (baseline vs. after supervised period vs. after self-supervised period). †p 0.05 and ††p 0.01 to between-group comparison (vs. control group).